Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06315517 · ClinicalTrials.gov registry record · NA
Double Crossover Casein Type Tolerance Trial
A NA study, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT06315517 is a NA study that has completed, run by Auburn University. The registered enrollment target is 48 participants.
The verdict
NCT06315517, a NA study, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The investigators will recruit 45 fluid milk avoiding adults to participate in a five-week double-blind, double-crossover study in which the physiological responses to increasing doses of lactose-free (A1-rich milk), A2 milk, and lactose-free A2 milk will be explored.
Interventions
- OTHER Conventional lactose-free cow's milk
- OTHER Nonconventional (A2) cow's milk
- OTHER Nonconventional (A2) lactose-free cow's milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-04-20 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06315517
The ClinicalTrials.gov registry entry for NCT06315517 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Conventional lactose-free cow's milk is the first listed.
NCT06315517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06315517 about?
NCT06315517 is a clinical study titled "Double Crossover Casein Type Tolerance Trial". The investigators will recruit 45 fluid milk avoiding adults to participate in a five-week double-blind, double-crossover study in which the physiological responses to increasing doses of lactose-free (A1-rich milk), A2 milk, and lactose-free A2 milk will be explored.
What is the current status of trial NCT06315517?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2024-04-20. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT06315517?
The interventions under investigation include: Conventional lactose-free cow's milk (OTHER), Nonconventional (A2) cow's milk (OTHER), Nonconventional (A2) lactose-free cow's milk (OTHER).
Who is sponsoring clinical trial NCT06315517?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.